69393-72-2

Basic information

• Product Name: 1,3-Benzodioxol-4-ol
• CAS NO: 69393-72-2
• Molecular Formula: C7H6O3
• Molecular Weight: 138.123
• Mol File: 69393-72-2.mol
• Article Data: 17

Chemical Properties

• CAS DataBase Reference: 1,3-Benzodioxol-4-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Benzodioxol-4-ol(69393-72-2)
• EPA Substance Registry System: 1,3-Benzodioxol-4-ol(69393-72-2)

Safety Data

• Hazardous Substances Data: 69393-72-2(Hazardous Substances Data)

Usage

General Description

1,3-Benzodioxol-4-ol, also known as piperonylic acid, is a chemical compound with the molecular formula C7H6O4. It is a white solid that is soluble in water and organic solvents. 1,3-Benzodioxol-4-ol is used in the synthesis of various pharmaceuticals and agrochemicals. It has also been investigated for its potential antioxidant and antimicrobial properties. The compound has a benzodioxole ring structure, which is a common motif in many natural products and biologically active molecules. 1,3-Benzodioxol-4-ol is regulated as a controlled substance in some countries due to its potential use in the illicit production of drugs such as methylenedioxymethamphetamine (MDMA).

Upstream product

• 75-11-6 diiodomethane 
• 87-66-1 2-hydroxyresorcinol 
• 7797-83-3 2H-benzo[d]1,3-dioxolane-4-carbaldehyde 
• 1817-95-4 4-methoxy-benzo[1,3]dioxole 
• 934-00-9 3-methocycatechol 
• 610-02-6 2,3,4-trihydroxybenzoic acid 
• 148-53-8 3-methoxy-2-hydroxybenzaldehyde 
• 24677-78-9 2,3-dihydroxybenzaldehyde 
• 74-95-3 1,1-dibromomethane 
• 4776-00-5 4-hydroxybenzo[d][1,3]dioxole-5-carboxylic acid 

Downstream Products

• 86319-80-4 1,4-dihydroxy-2,3-methylenedioxybenzene 
• 92830-78-9 (benzyloxy-2 methylenedioxy-3,4 benzyl)-4 <(trimethoxy-3,4,5-phenyl)hydroxymethyl>-3 dihydro-3H-furannone-2 
• 1355330-18-5 5-(1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazol-5-yl)benzo[d][1,3]dioxol-4-ol 
• 1355330-34-5 5-(4-(methoxymethoxy)benzo[d][1,3]dioxol-5-yl)-1-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole 
• 523-80-8 apiol 
• 82314-35-0 (5aS,8aR)-10-Benzyloxy-5-hydroxy-5-(3,4,5-trimethoxy-phenyl)-5,8,8a,9-tetrahydro-5aH-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6-one 
• 82299-45-4 (5aR,8aR)-10-Benzyloxy-5-(3,4,5-trimethoxy-phenyl)-5,8,8a,9-tetrahydro-5aH-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6-one 
• 477-50-9 (+/-)-iso β-peltatine 
• 82299-45-4 O-benzyl (+/-)-iso-β-peltatine 
• 477-50-9 (+/-)-iso-β-peltatine 
• 82299-38-5 acide (benzyloxy-2 methylenedioxy-3,4 phenyl)-4 methoxycarbonyl-3 butene-3 oique 
• 82299-39-6 (benzyloxy-2 methylenedioxy-3,4 benzylidene)-4 dihydro-3H-furannone-2 

Relevant articles and documents

VASCULAR ADHESION PROTEIN-1 (VAP-1) MODULATORS AND THERAPEUTIC USES THEREOF

Disclosed herein are small molecule Vascular Adhesion Protein- 1 (VAP-1) modulator compositions, pharmaceutical compositions, the use and preparation thereof.

INHIBITORS OF THE BCL6 BTB DOMAIN PROTEIN-PROTEIN INTERACTION AND USES THEREOF

The present application relates to compounds of Formula I (I) or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, to compositions comprising these compounds or pharmaceutically acceptable salts, solvates and/or prodrugs thereof, and various uses in the treatment of diseases, disorders or conditions that are treatable by inhibiting interactions with BCL6 BTB, such as cancer.

CONFORMATIONALLY-CONSTRAINED BIOISOSTERES OF CAFFEIC ACID, AND SYNTHESIS AND THERAPEUTIC USES

A method of treating a disease condition in a mammal comprising administering a pharmacologically effective amount of a therapeutic, wherein the therapeutic includes a bioisosteres of caffeic acid. A pharmaceutical composition for treating a disease condition in a mammal comprising a first therapeutic that includes a bioisosteres of caffeic acid, wherein the condition may be breast cancer, and the pharmaceutical composition may include a second therapeutic for the disease condition that is not a bioisosteres of caffeic acid.